Search for: "Astra Zeneca Pharmaceuticals" Results 1 - 20 of 36
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Jun 2023, 8:00 am by Eugene Volokh
Astra Zeneca Pharmaceuticals, LP, (MN App., June 12, 2023), was the only one of the four cases published as a precedential decision. [read post]
13 Jun 2023, 4:05 am by Howard Friedman
Astra Zeneca Pharmaceuticals, LP, (MN App., June 12, 2023), was the only one of the four cases published as a precedential decision. [read post]
6 Apr 2022, 6:35 am by The Petrie-Flom Center Staff
For example, although Astra Zeneca did not aim to maximize profits at the beginning of the pandemic, it declared low-cost pricing for its COVID-19 vaccine to be over before the Omicron wave started. [read post]
15 Aug 2021, 11:51 pm by Radhi Shah (USC Gould School of Law)
AstraZeneca   The following case illustrates license sought for Saxagliptin® which is used in the treatment of Type-II Diabetes Mellitus On June 29, 2015, Lee Pharma filed an application for compulsory license for patent covering Astra Zeneca’s diabetes management drug Saxagliptin®. [read post]
13 Jul 2021, 7:18 am by Neil Wilkof
The Oxford-Astra Zeneca vaccine, the J&J vaccine, the Novovax vaccine and the Russian Sputnik vaccine have all been licensed to Indian companies for manufacture and distribution within India and, in some cases, for the rest of the developing world. [read post]
5 May 2021, 9:34 am by Kluwer Patent blogger
As the BBC commented in an analysis: “Unlike rivals Astra Zeneca and Johnson & Johnson which vowed to forego profits on the vaccine during the pandemic, Pfizer planned to make money on its vaccines. [read post]
5 May 2021, 9:34 am by Kluwer Patent blogger
As the BBC commented in an analysis: “Unlike rivals Astra Zeneca and Johnson & Johnson which vowed to forego profits on the vaccine during the pandemic, Pfizer planned to make money on its vaccines. [read post]
14 Apr 2021, 6:49 am by Matthieu Dhenne (Ipsilon)
Similarly, Oxford University holds patents on the recombinant DNA technology used in Astra Zeneca’s vaccine, to which Oxford University has granted an exclusive license[4]. [read post]
27 Jan 2021, 1:44 pm by Kevin LaCroix
After the coronavirus outbreak became widespread in early 2020, AstraZeneca was one of several pharmaceutical companies to become involved in efforts to develop a COVID-19 vaccine. [read post]
8 Oct 2020, 7:26 am by Michael Geist
Years of publicly funded research has been essential in supporting the race to find an effective COVID-19 vaccine, serving as the foundation for the Astra-Zeneca/Oxford vaccine candidate. [read post]
3 Jun 2020, 1:06 am by Roya Ghafele (OxFirst)
In the UK the government bets on a collaboration between Oxford University and the British Pharmaceutical Company Astra Zeneca. [read post]
19 Dec 2013, 8:56 pm by Lawrence B. Ebert
The written description describes the invention clearly and narrowly as including only those salts, and Astra- Zeneca points to nothing in the intrinsic record that is sufficient to overcome that disclaimer.Of backgroundAstraZeneca discovered that certain salts of an omeprazole enantiomer, as opposed to the racemate, have “improved pharmacokinetic and metabolic properties which will give an improved therapeutic profile such as a lower degree of interindividual variation. [read post]
31 Jan 2013, 3:44 am by Ben Vernia
Astra-Zeneca Pharmaceuticals LP, a whistleblower case brought by a former vice president of pharmaceutical contracting for the pharmacy benefits manager (PBM), Medco. [read post]
8 May 2012, 9:53 am by jleaming@acslaw.org
Astra Zeneca, Johnson & Johnson and Pfizer have all paid hefty fines following allegations of marketing derelictions. read more [read post]
4 Apr 2012, 2:30 am
With so many popular antidepressants' exclusivity patents getting ready to expire soon and more recent drugs to hit the market like Astra Zeneca failing, many drug manufacturers just lost interest in developing newer drugs. [read post]
16 Sep 2011, 11:02 am by eithurburn@getnicklaw.com
  The state has already settled cases with Astra Zeneca, Abbott Laboratories, GlaxoSmithKline, Amgen Inc., Baxter Healthcare Corp., Boehringer Ingelhelm Roxane, and Dey Pharmaceutical and has prevailed at trial against Johnson & Johnson and Bristol-Meyers Squibb. [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]
25 May 2011, 5:47 am by LaBovick Law
The eight pharmaceutical manufacturers in the case included subsidiaries of Astra Zeneca, Sanofi-Aventis SA, Bayer AG, Takeda Pharmaceutical, Bristol Myers Squibb, Merck, Pfizer and GlaxoSmithKine. [read post]